Millions of Michiganders who rely on Medicaid for weight management medications could face coverage losses in 2026 as part of proposed state budget changes. In this Expert Q&A, Michigan Medicine physicians explain how limiting access to GLP-1 drugs may affect patients and why state lawmakers should reconsider the decision.
